More Effective Violence Risk Management - eDASA+APP FI (eDASA+APP FI)

March 26, 2024 updated by: Tella Lantta, University of Turku

More Effective Violence Risk Management for Psychiatric Wards - eDASA+APP FI

The main goal of this study is to evaluate if the Finnish version of eDASA+APP (electronic Dynamic Appraisal of Situational Aggression + Aggression Prevention Protocol), a clinical decision support system (CDSS), has an impact on reducing workplace violence, use of coercive measures and increasing nurses' job satisfaction in adult psychiatric inpatient care.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The study includes three phases: 1) exploring attitudes of nurses and nurse managers towards validated tools, violence risk assessment and management, 2) a pre-implementation including a co-design process of the eDASA+APP to ensure optimal integration and adaptation to local context and integration into the local EPIC based EHR system together with relevant stakeholders (health care staff and expert-by-experience), and 3) a quasi-experimental implementation study to evaluate the impact of the intervention (eDASA+APP FI).

Study Type

Interventional

Enrollment (Estimated)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • adult psychiatric wards

Exclusion Criteria:

  • psychiatric wards specialized only for the care of people with intellectual disabilities, wards providing care for both adults and underaged patients (eating disorder units)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: eDASA+APP FI
Nurses in the study wards are using a CDSS 'eDASA+APP FI' in their daily clinical work to aid their short-term violence risk assessment and management, together with a patient if possible, to identify patients at elevated risk for violence in the coming 24 hours and to decrease (or maintain low) the risk with evidence-based, non-invasive nursing interventions.
Behavioral: eDASA+APP FI
A CDSS for nurses to assist in their daily short-term violence risk assessment and management, is integrated into an EPIC-based EHR system.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Workplace violence
Time Frame: Pre-post (3 months)
Violence experienced by healthcare staff in the wards, routinely collected data
Pre-post (3 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Coercive measures
Time Frame: Pre-post (3 months)
Routinely monitored and collected by the wards according to the Finnish Mental Health Act
Pre-post (3 months)
Job satisfaction
Time Frame: Pre-post (3 months)
Nurses yearly job satisfaction survey will be used (Nurse Engagement Survey (NESplus))
Pre-post (3 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Turku

Collaborators

Helsinki University Central Hospital

Investigators

  • Principal Investigator: Tella Lantta, PhD, Department of Nursing Science, University of Turku, Finland

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2024

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

March 26, 2024

First Submitted That Met QC Criteria

March 26, 2024

First Posted (Actual)

April 2, 2024

Study Record Updates

Last Update Posted (Actual)

April 2, 2024

Last Update Submitted That Met QC Criteria

March 26, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 210324

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Violence

Clinical Trials on eDASA+APP FI

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe